During the past decade, Alaska Women's Cancer Care conducted 148 clinical trials. In the 10-year time frame, 148 clinical trials started and 64 clinical trials were completed, i.e. on average, 43.2% percent of trials that started reached the finish line to date. In the past 5 years, 63 clinical trials started and 55 clinical trials were completed. i.e. 87.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Alaska Women's Cancer Care" #1 sponsor was "National Cancer Institute (NCI)" with 90 trials, followed by "Alliance for Clinical Trials in Oncology" with 35 trials sponsored, "SWOG Cancer Research Network" with 31 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 17 trials sponsored and "Gynecologic Oncology Group" with 17 trials sponsored. Other sponsors include 8 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Alaska Women's Cancer Care" #1 collaborator was "National Cancer Institute (NCI)" with 98 trials as a collaborator, "NRG Oncology" with 20 trials as a collaborator, "Canadian Cancer Trials Group" with 11 trials as a collaborator, "Genentech, Inc." with 3 trials as a collaborator and "AstraZeneca" with 2 trials as a collaborator. Other collaborators include 21 different institutions and companies that were collaborators in the rest 30 trials.

According to Clinical.Site data, the most researched conditions in "Alaska Women's Cancer Care" are "Recurrent Ovarian Carcinoma" (9 trials), "Recurrent Squamous Cell Lung Carcinoma" (8 trials), "Invasive Breast Carcinoma" (7 trials), "Stage IV Lung Cancer AJCC v8" (7 trials) and "Ovarian Seromucinous Carcinoma" (6 trials). Many other conditions were trialed in "Alaska Women's Cancer Care" in a lesser frequency.

Most popular intervention types in "Alaska Women's Cancer Care" are "Drug" (158 trials), "Other" (114 trials), "Biological" (83 trials), "Procedure" (54 trials) and "Radiation" (26 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (56 trials), "Quality-of-Life Assessment" (48 trials), "Computed Tomography" (32 trials), "Questionnaire Administration" (30 trials) and "Biospecimen Collection" (28 trials). Other intervention names were less common.

The vast majority of trials in "Alaska Women's Cancer Care" are 155 trials for "All" genders, 35 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Alaska Women's Cancer Care". undefined are not yet recruiting, 60 are recruiting, 94 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 25 completed trials in Alaska Women's Cancer Care, 5 suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in Alaska Women's Cancer Care, 6 "Phase 1" clinical trials were conducted, 102 "Phase 2" clinical trials and 94 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 4 trials that are defined as “Not Applicable".